| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)
IRWD Technical Analysis
1.5
| As on 9th Jun 2023 IRWD STOCK Price closed @ 11.42 and we RECOMMEND Sell for LONG-TERM with Stoploss of 11.42 & Buy for SHORT-TERM with Stoploss of 11.24 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IRWDSTOCK Price
| Open | 11.59 | Change | Price | % |
| High | 11.67 | 1 Day | -0.18 | -1.55 |
| Low | 11.40 | 1 Week | 0.54 | 4.96 |
| Close | 11.42 | 1 Month | 1.00 | 9.60 |
| Volume | 1652700 | 1 Year | -0.01 | -0.09 |
| 52 Week High 12.88 | 52 Week Low 9.90 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IRWD Daily Charts |
IRWD Intraday Charts |
Whats New @ Bazaartrend |
IRWD Free Analysis |
|
|
IRWD Important Levels Intraday
| RESISTANCE | 11.94 |
| RESISTANCE | 11.77 |
| RESISTANCE | 11.67 |
| RESISTANCE | 11.57 |
| SUPPORT | 11.27 |
| SUPPORT | 11.17 |
| SUPPORT | 11.07 |
| SUPPORT | 10.90 |
IRWD Forecast April 2024
| 4th UP Forecast | 15.06 |
| 3rd UP Forecast | 13.89 |
| 2nd UP Forecast | 13.17 |
| 1st UP Forecast | 12.45 |
| 1st DOWN Forecast | 10.39 |
| 2nd DOWN Forecast | 9.67 |
| 3rd DOWN Forecast | 8.95 |
| 4th DOWN Forecast | 7.78 |
IRWD Weekly Forecast
| 4th UP Forecast | 12.40 |
| 3rd UP Forecast | 12.09 |
| 2nd UP Forecast | 11.89 |
| 1st UP Forecast | 11.70 |
| 1st DOWN Forecast | 11.14 |
| 2nd DOWN Forecast | 10.95 |
| 3rd DOWN Forecast | 10.75 |
| 4th DOWN Forecast | 10.44 |
IRWD Forecast2024
| 4th UP Forecast | 17.62 |
| 3rd UP Forecast | 15.63 |
| 2nd UP Forecast | 14.4 |
| 1st UP Forecast | 13.17 |
| 1st DOWN Forecast | 9.67 |
| 2nd DOWN Forecast | 8.44 |
| 3rd DOWN Forecast | 7.21 |
| 4th DOWN Forecast | 5.22 |
Ironwood Pharmaceuticals Inc ( NASDAQ USA Symbol : IRWD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IRWD Business Profile
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts. Address: 100 Summer Street, Boston, MA, United States, 02110
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service